Top

Published in:

01-05-2011 | Original Contribution

Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity

Authors: Xiulan Yang, Yanping Liu, Xi-Ming Yang, Fangdi Hu, Lin Cui, Mark R. Swingle, Richard E. Honkanen, Peyman Soltani, Renaud Tissier, Michael V. Cohen, James M. Downey

Published in: Basic Research in Cardiology | Issue 3/2011

Abstract

Cooling the ischemic heart by just a few degrees protects it from infarction without affecting its mechanical function, but the mechanism of this protection is unknown. We investigated whether signal transduction pathways might be involved in the anti-infarct effect of mild hypothermia (35°C). Isolated rabbit hearts underwent 30 min of coronary artery occlusion/2 h of reperfusion. They were either maintained at 38.5°C or cooled to 35°C just before and only during ischemia. Infarct size was measured. The effects of the protein kinase C inhibitor chelerythrine, the nitric oxide synthase inhibitor N ^ω-nitro-l-arginine methyl ester (l-NAME), the phosphatidylinositol 3-kinase antagonist wortmannin, or either of the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitors PD98059 or U0126 on cooling’s protection were examined. Myocardial ATP assays were performed and the level of phosphorylation of extracellular signal-regulated kinase (ERK) and MEK was examined by western blotting. To investigate an effect of cooling on protein phosphatase (PPase), a PPase inhibitor cantharidin was tested in the infarct model and the effect of mild hypothermia on PP2A activity in vitro was measured. Infarct size was 34.4 ± 2.2% of the ischemic zone in normothermic (38.5°C) hearts, but only 15.6 ± 8.7% in hearts cooled to 35°C during ischemia. Mechanical function was unaffected. Neither chelerythrine, l-NAME, nor wortmannin had any effect, but both PD98059 and U0126 completely eliminated protection. Ischemia rather than reperfusion was the critical time when ERK had to be active to realize protection. Phosphorylation of ERK and MEK fell during normothermic ischemia, but during hypothermic ischemia phosphorylation of ERK remained high while that of MEK was increased. Cooling only slightly delayed the rate at which ATP fell during ischemia, and ERK inhibition did not affect that attenuation suggesting ATP preservation was unrelated to protection. Cantharidin, like cooling, also protected during ischemia but not at reperfusion, and its protection was dependent on ERK phosphorylation. However, mild hypothermia had a negligible effect on PP2A activity in an in vitro assay. Hence, mild hypothermia preserves ERK and MEK activity during ischemia which somehow protects the heart. While a PPase inhibitor mimicked cooling’s protection, a direct effect of cooling on PP2A could not be demonstrated.

Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489–27494. doi:10.1074/jbc.270.46.27489 PubMedCrossRef

Armstrong SC, Gao W, Lane JR, Ganote CE (1998) Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia. J Mol Cell Cardiol 30:61–73. doi:10.1006/jmcc.1997.0572 PubMedCrossRef

Broadley KJ, Broome S, Paton DM (1985) Hypothermia-induced supersensitivity to adenosine for responses mediated via A₁-receptors but not A₂-receptors. Br J Pharmacol 84:407–415PubMed

Chien GL, Wolff RA, Davis RF, VanWinkle DM (1994) “Normothermic range” temperature affects myocardial infarct size. Cardiovasc Res 28:1014–1017. doi:10.1093/cvr/28.7.1014 PubMedCrossRef

Dae MW, Gao DW, Sessler DI, Chair K, Stillson CA (2002) Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs. Am J Physiol 282:H1584–H1591. doi:10.1152/ajpheart.00980.2001

Duncia JV, Santella JB III, Higley CA, Pitts WJ, Wityak J, Frietze WE, Rankin FW, Sun J-H, Earl RA, Tabaka AC, Teleha CA, Blom KF, Favata MF, Manos EJ, Daulerio AJ, Stradley DA, Horiuchi K, Copeland RA, Scherle PA, Trzaskos JM, Magolda RL, Trainor GL, Wexler RR, Hobbs FW, Olson RE (1998) MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett 8:2839–2844. doi:10.1016/S0960-894X(98)00522-8

Duncker DJ, Klassen CL, Ishibashi Y, Herrlinger SH, Pavek TJ, Bache RJ (1996) Effect of temperature on myocardial infarction in swine. Am J Physiol 270:H1189–H1199PubMed

Fan WJ, van Vuuren D, Genade S, Lochner A (2010) Kinases and phosphatases in ischaemic preconditioning: a re-evaluation. Basic Res Cardiol 105:495–511. doi:10.1007/s00395-010-0086-3 PubMedCrossRef

Götberg M, Olivecrona GK, Engblom H, Ugander M, van der Pals J, Heiberg E, Arheden H, Erlinge D (2008) Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size. BMC Cardiovasc Disord 8:7. doi:10.1186/1471-2261-8-7

10.

Gustafsson ÅB, Gottlieb RA (2008) Heart mitochondria: gates of life and death. Cardiovasc Res 77:334–343. doi:10.1093/cvr/cvm005 PubMedCrossRef

11.

Haendchen RV, Corday E, Meerbaum S, Povzhitkov M, Rit J, Fishbein MC (1983) Prevention of ischemic injury and early reperfusion derangements by hypothermic retroperfusion. J Am Coll Cardiol 1:1067–1080. doi:10.1016/S0735-1097(83)80109-0 PubMedCrossRef

12.

Hale SL, Dave RH, Kloner RA (1997) Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia. Basic Res Cardiol 92:351–357. doi:10.1007/s003950050044 PubMed

13.

Hale SL, Kloner RA (1997) Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia. Am J Physiol 273:H220–H227PubMed

14.

Hausenloy DJ, Baxter G, Bell R, Bøtker HE, Davidson SM, Downey J, Heusch G, Kitakaze M, Lecour S, Mentzer R, Mocanu MM, Ovize M, Schulz R, Shannon R, Walker M, Walkinshaw G, Yellon DM (2010) Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol 105:677–686. doi:10.1007/s00395-010-0121-4 PubMedCrossRef

15.

Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol 288:H971–H976. doi:10.1152/ajpheart.00374.2004

16.

Hausenloy DJ, Yellon DM (2004) New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61:448–460. doi:10.1016/j.cardiores.2003.09.024 PubMedCrossRef

17.

Hausenloy DJ, Yellon DM, Mani-Babu S, Duchen MR (2004) Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol 287:H841–H849. doi:10.1152/ajpheart.00678.2003

18.

Herbert JM, Augereau JM, Gleye J, Maffrand JP (1990) Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172:993–999. doi:10.1016/0006-291X(90)91544-3 PubMedCrossRef

19.

Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915–1919. doi:10.1161/CIRCULATIONAHA.108.805242 PubMedCrossRef

20.

Heusch G, Boengler K, Schulz R (2010) Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res Cardiol 105:151–154. doi:10.1007/s00395-009-0080-9 PubMedCrossRef

21.

Honkanen RE (1993) Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett 330:283–286. doi:10.1016/0014-5793(93)80889-3 PubMedCrossRef

22.

Jones RN, Reimer KA, Hill ML, Jennings RB (1982) Effect of hypothermia on changes in high-energy phosphate production and utilization in total ischemia. J Mol Cell Cardiol 14(Suppl 3):123–130

23.

Kanemoto S, Matsubara M, Noma M, Leshnower BG, Parish LM, Jackson BM, Hinmon R, Hamamoto H, Gorman JH III, Gorman RC (2009) Mild hypothermia to limit myocardial ischemia–reperfusion injury: importance of timing. Ann Thorac Surg 87:157–163. doi:10.1186/1471-2261-8-7 PubMedCrossRef

24.

Kim SO, Baines CP, Critz SD, Pelech SL, Katz S, Downey JM, Cohen MV (1999) Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart. Biochem Cell Biol 77:559–567. doi:10.1139/bcb-77-6-559 PubMedCrossRef

25.

Ly HQ, Denault A, Dupuis J, Vadeboncoeur A, Harel F, Arsenault A, Gibson CM, Bonan R (2005) A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (The NICAMI Study). Am Heart J 150:933.e9–933.e13. doi:10.1016/j.ahj.2005.02.049

26.

Maeng M, Mortensen UM, Kristensen J, Kristiansen SB, Andersen HR (2006) Hypothermia during reperfusion does not reduce myocardial infarct size in pigs. Basic Res Cardiol 101:61–68. doi:10.1007/s00395-005-0550-7 PubMedCrossRef

27.

Masino SA, Dunwiddie TV (1999) Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine. J Neurosci 19:1932–1939. doi:10.1016/S0306-4522(99)00404-2 PubMed

28.

Miki T, Liu GS, Cohen MV, Downey JM (1998) Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res Cardiol 93:372–383. doi:10.1007/s003950050105 PubMedCrossRef

29.

National Research Council (1996) Guide for the care and use of laboratory animals, 7th edn. National Academy Press, Washington, DC

30.

Ni L, Swingle MS, Bourgeois AC, Honkanen RE (2007) High yield expression of serine/threonine protein phosphatase type 5, and a fluorescent assay suitable for use in the detection of catalytic inhibitors. Assay Drug Dev Technol 5:645–653. doi:10.1089/adt.2007.079 PubMedCrossRef

31.

O’Neill WW, Dixon SR (2004) The year in interventional cardiology. J Am Coll Cardiol 43:875–890. doi:10.1016/j.jacc.2003.12.024 PubMedCrossRef

32.

O’Neill WW, Dixon SR, Grines CL (2005) The year in interventional cardiology. J Am Coll Cardiol 45:1117–1134. doi:10.1016/j.jacc.2005.01.006 PubMedCrossRef

33.

Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G, Vlahos CJ (1994) Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 54:2419–2423. doi:10.1007/BF00686043 PubMed

34.

Shao Z-H, Chang W-T, Chan KC, Wojcik KR, Hsu C-W, Li C-Q, Li J, Anderson T, Qin Y, Becker LB, Hamann KJ, Vanden Hoek TL (2007) Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling. Am J Physiol 292:H1995–H2003. doi:10.1152/ajpheart.01312.2005

35.

Shao Z-H, Sharp WW, Wojcik KR, Li C-Q, Han M, Chang W-T, Ramachandran S, Li J, Hamann KJ, Vanden Hoek TL (2010) Therapeutic hypothermia cardioprotection via Akt- and nitric oxide-mediated attenuation of mitochondrial oxidants. Am J Physiol 298:H2164–H2173. doi:10.1152/ajpheart.00994.2009

36.

Simkhovich BZ, Hale SL, Kloner RA (2004) Metabolic mechanism by which mild regional hypothermia preserves ischemic tissue. J Cardiovasc Pharmacol Ther 9:83–90. doi:10.1177/107424840400900203 PubMedCrossRef

37.

Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G (2009) Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104:15–18. doi:10.1161/CIRCRESAHA.108.186429 PubMedCrossRef

38.

Solenkova NV, Solodushko V, Cohen MV, Downey JM (2006) Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol 290:H441–H449. doi:10.1152/ajpheart.00589.2005

39.

Swingle M, Ni L, Honkanen RE (2007) Small molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. Methods Mol Biol 365:23–38. doi:10.1385/1-59745-267-X:23 PubMed

40.

Tissier R, Hamanaka K, Kuno A, Parker JC, Cohen MV, Downey JM (2007) Total liquid ventilation provides ultra-fast cardioprotective cooling. J Am Coll Cardiol 49:601–605. doi:10.1016/j.jacc.2006.09.041 PubMedCrossRef

41.

Weinbrenner C, Baines CP, Liu G-S, Armstrong SC, Ganote CE, Walsh AH, Honkanen RE, Cohen MV, Downey JM (1998) Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Circulation 98:899–905PubMed

42.

Wunder F, Buehler G, Hüser J, Mundt S, Bechem M, Kalthof B (2007) A cell-based nitric oxide reporter assay useful for the identification and characterization of modulators of the nitric oxide/guanosine 3′,5′-cyclic monophosphate pathway. Anal Biochem 363:219–227. doi:10.1016/j.ab.2007.02.001 PubMedCrossRef

43.

Yang X-M, Krieg T, Cui L, Downey JM, Cohen MV (2004) NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 36:411–421. doi:10.1016/j.yjmcc.2003.12.008 PubMedCrossRef

Title: Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity
Authors: Xiulan Yang
Yanping Liu
Xi-Ming Yang
Fangdi Hu
Lin Cui
Mark R. Swingle
Richard E. Honkanen
Peyman Soltani
Renaud Tissier
Michael V. Cohen
James M. Downey
Publication date: 01-05-2011
Publisher: Springer-Verlag
Published in: Basic Research in Cardiology / Issue 3/2011
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-011-0165-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure

Effects of high thoracic epidural anesthesia on atrial electrophysiological characteristics and sympathetic nerve sprouting in a canine model of atrial fibrillation

Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats

Cardiac-specific overexpression of E3 ligase Nrdp1 increases ischemia and reperfusion-induced cardiac injury

A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart

Deficiency in TIMP-3 increases cardiac rupture and mortality post-myocardial infarction via EGFR signaling: beneficial effects of cetuximab